Previous reports have demonstrated that the treatment both in vitro and in vivo in AD experimental models with natural antioxidants was able to modulate the intracellular levels of tissue transglutaminase (TG2) and its isoforms [4,5,6]. The gene discussed is TGM2; the disease is Alzheimer disease.